Centessa Pharmaceuticals PLC
F:260
Centessa Pharmaceuticals PLC
F:260
Price:
33.4
EUR
1.83%
Market Cap:
€3.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Centessa Pharmaceuticals PLC
F:260
|
UK |
|
C
|
China Merchants Bank Co Ltd
OTC:CIHHF
|
CN |
|
C
|
CenterPoint Energy Inc
XBER:HOU
|
US |
|
Atlantica Sustainable Infrastructure PLC
NASDAQ:AY
|
UK |
|
Globaltrans Investment PLC
LSE:GLTR
|
CY |
|
R
|
Regis Corp
XBER:RGI
|
US |
|
S
|
Sandvik AB
XMUN:SVKB
|
SE |
|
Valneva SE
NASDAQ:VALN
|
FR |
|
Reckitt Benckiser Group PLC
OTC:RBGPD
|
UK |
|
Carnival Corp
NYSE:CCL
|
US |
|
Advanced Drainage Systems Inc
NYSE:WMS
|
US |
|
S
|
Sumitomo Electric Industries Ltd
DUS:SMO
|
JP |
|
B
|
Bridgestone Corp
SWB:BGT
|
JP |
|
E
|
Euroapi SAS
LSE:0EAP
|
FR |
|
C
|
Centrotec SE
XHAM:CEV
|
DE |
|
P
|
PayPay Corp
NASDAQ:PAYP
|
JP |
|
Peach Property Group AG
F:P6Z
|
CH |
|
N
|
National Bank of Canada
XMUN:NBC
|
CA |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
Multiples-Based Value
The Multiples-Based Value for 
Centessa Pharmaceuticals PLC (260) under the Base Case is hidden
EUR.
Compared with the current market price of 33.4 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Centessa Pharmaceuticals PLC Multiples-Based Value
LOCKED
